Nabumetone and Gastroesophageal reflux disease - a phase IV clinical study of FDA data

Summary:

Gastroesophageal reflux disease is found among people who take Nabumetone, especially for people who are female, 60+ old, have been taking the drug for 10+ years.

The phase IV clinical study analyzes which people take Nabumetone and have Gastroesophageal reflux disease. It is created by eHealthMe based on reports of 8,182 people who have side effects when taking Nabumetone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trials. Phase IV trials are used to detect adverse drug outcomes and monitor effectiveness after drugs are approved to the market. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jul, 13, 2022

8,182 people reported to have side effects when taking Nabumetone.
Among them, 155 people (1.89%) have Gastroesophageal reflux disease.


What is Nabumetone?

Nabumetone has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 8,594 Nabumetone users for its effectiveness, alternative drugs and more.

What is Gastroesophageal reflux disease?

Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus) is found to be associated with 3,438 drugs and 3,024 conditions by eHealthMe.

Number of Nabumetone and Gastroesophageal reflux disease reports submitted per year:

Could Nabumetone cause Gastroesophageal reflux disease?

Time on Nabumetone when people have Gastroesophageal reflux disease *:

Click here to view

Gender of people who have Gastroesophageal reflux disease when taking Nabumetone*:

Click here to view

Age of people who have Gastroesophageal reflux disease when taking Nabumetone *:

Click here to view

Common drugs people take besides Nabumetone *:

Click here to view

Common side effects people have besides Gastroesophageal reflux disease *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Nabumetone and have Gastroesophageal reflux disease?

Check whether Gastroesophageal reflux disease is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Gastroesophageal reflux disease and when was it recovered:

Expand to all the drugs that have ingredients of nabumetone:

Alternative drugs to, pros and cons of Nabumetone:

Common Nabumetone side effects:

Browse all side effects of Nabumetone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Gastroesophageal reflux disease treatments and more:

COVID vaccines that are related to Gastroesophageal reflux disease:

Common drugs associated with Gastroesophageal reflux disease:

All the drugs that are associated with Gastroesophageal reflux disease:

Common conditions associated with Gastroesophageal reflux disease:

All the conditions that are associated with Gastroesophageal reflux disease:

How the study uses the data?

The study uses data from the FDA. It is based on nabumetone (the active ingredients of Nabumetone) and Nabumetone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: